Shabir Ahmad Lone

Shabir Ahmad Lone

Auto-generated profile, based on publicly available information

Shabir Ahmad Lone

Clinical Microbiology and Infectious Diseases, School of Pathology, Health Sciences, University of the Witwatersrand, Johannesburg, 2193, South Africa

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Emerging Microbes & Infections
Verified
Journal Article
Open access
SLShabir Ahmad Lone
Shabir Ahmad Lone
AAAijaz Ahmad
Aijaz Ahmad
The recently emerged novel coronavirus, “severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)”, caused a highly contagious disease called coronavirus disease 2019 (COVID-19). The virus was first reported from Wuhan city in China in December, 2019, which in less than three months spread throughout the globe and was declared a global pandemic by the World Health Organization (WHO) on 11th of March, 2020. So far, the ongoing pandemic severely damaged the world’s most developed countries and is becoming a major threat for low- and middle-income countries. The poorest continent, Africa with the most vulnerable populations to infectious diseases, is predicted to be significantly affected by the ongoing COVID-19 outbreak. Therefore, in this review we collected and summarised the currently available literature on the epidemiology, etiology, vulnerability, preparedness and economic impact of COVID-19 in Africa, which could be useful and provide necessary information on ongoing COVID-19 pandemics in the continent. We also briefly summarised the concomitance of the COVID-19 pandemic and global warming.

17 February 2019 in Mycoses
Verified
Journal Article
Closed access
PDF file
SLShabir Ahmad Lone
Shabir Ahmad Lone
AAAijaz Ahmad
Aijaz Ahmad

1 July 2019 in Heliyon
Verified
Journal Article
Open access
ODOvas Ahmad Dar
Ovas Ahmad Dar
SLShabir Ahmad Lone
Shabir Ahmad Lone
MMManzoor Ahmad Malik
Manzoor Ahmad Malik
FAFaisal Mohammed Aqlan
Faisal Mohammed Aqlan
MWMohammad Younus Wani
Mohammad Younus Wani
AAAijaz Ahmad
Aijaz Ahmad
Metal based drugs are important class of chemotherapeutic agents that have the potential to circumvent drug resistance. Increasing drug resistance, treatment failures and limited treatment options necessitates the development of new therapeutic drugs with different mechanisms of action. Towards this direction, we synthesized a series of isatin based mixed ligand complexes of [Cu(dbm)LClH2O] (mlc1), [Co(dbm)LCl2]‒ (mlc2) and [Ni(dbm)LClH2O] (mlc3) and evaluated their antifungal activity alone and in combination with fluconazole (FLC) against seven different Candida albicans isolates. The insight mechanism of antifungal action was revealed by studying apoptosis via terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay. The study revealed that all these compounds showed antifungal activity at varying concentrations with mlc3 as the most potent compound with minimum inhibitory concentration ranging from 0.5-8 μg/mL and minimum fungicidal concentration ranging from 4-16 μg/mL. Upon combination with FLC, most of the interactions were either synergistic (54 %) or additive (32 %) with no antagonistic combination against any of the tested isolate. The study on their mechanism of action revealed that these compounds show apoptotic effect on C. albicans at sub-inhibitory concentrations, suggesting that strategies to target this process may augment the current antifungal treatment modalities.

1 May 2020 in Bioorganic Chemistry
Verified
Journal Article
Closed access
MMManzoor Ahmad Malik
Manzoor Ahmad Malik
SLShabir Ahmad Lone
Shabir Ahmad Lone
MWMohammad Younus Wani
Mohammad Younus Wani
ITIkbal Ahmed Talukdar
Ikbal Ahmed Talukdar
ODOvas Ahmad Dar
Ovas Ahmad Dar
AHAthar Adil Hashmi
Athar Adil Hashmi

3 January 2021 in Archives of Microbiology
Verified
Journal Article
Closed access
PDF file
NBNikayla Batohi
Nikayla Batohi
SLShabir Ahmad Lone
Shabir Ahmad Lone
MMMusa Marimani
Musa Marimani
MWMohammad Younus Wani
Mohammad Younus Wani
AAAbdullah Saad Al-Bogami
Abdullah Saad Al-Bogami
AAAijaz Ahmad
Aijaz Ahmad

27 January 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SLShabir Ahmad Lone
Shabir Ahmad Lone
MWMohammad Younus Wani
Mohammad Younus Wani
PFPascaline Fru
Pascaline Fru
AAAijaz Ahmad
Aijaz Ahmad
Despite the rise of new Candida species, Candida albicans tops the list with high morbidity and mortality rates. To tackle this problem there is a need to explore new antifungals that could replace or augment the current treatment options. We previously reported that tosylation of eugenol on hydroxyl group resulted in molecules with enhanced antifungal potency. In line with that work, we synthesized new eugenol tosylate congeners (ETC-1–ETC-7) with different substituents on pendent sulfonyl group and tested their susceptibility against different fluconazole susceptible and resistant C. albicans strains. We evaluated physiology and mode of cell death in response to the most active derivatives by analyzing major apoptotic markers in yeast such as phosphatidylserine externalization, DNA fragmentation, mitochondrial depolarization and decrease in cytochrome c oxidase activity. The results demonstrated that all C. albicans strains were variably susceptible to the test compounds with MIC ranging from 0.125–512 µg/ml, and the most active compounds (ETC-5, ETC-6 and ETC-7) actuate apoptosis and necrosis in Candida cells in a dose-dependent manner via metacaspase-dependent pathway. Furthermore haemolytic assay showed low cytotoxicity effect of these ETCs. Overall the results indicated that ETCs exhibit potential antifungal activity against C. albicans by activating apoptotic and necrotic pathways.